These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 12872475)

  • 1. [Utilization of anti-ulcer agents: a screw without end?].
    Tøttrup A
    Ugeskr Laeger; 2003 Jun; 165(24):2501; author reply 2501. PubMed ID: 12872475
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preparations against stomach ulcer: use, prices and subsidy before and after 27 March 1989].
    Nissen A
    Ugeskr Laeger; 1991 May; 153(20):1436-7. PubMed ID: 2028558
    [No Abstract]   [Full Text] [Related]  

  • 3. [Increasing drug costs. The society's drug expenditures are strongly increasing. If this trend continues we have to make other priorities].
    Andreasen J
    Ugeskr Laeger; 2003 Jul; 165(29):2873-6. PubMed ID: 12908355
    [No Abstract]   [Full Text] [Related]  

  • 4. Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients.
    Heidelbaugh JJ; Inadomi JM
    Am J Gastroenterol; 2006 Oct; 101(10):2200-5. PubMed ID: 16952283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of antiasthmatic agents in Denmark during 1979-1989. Do we overuse antiasthmatic drugs?].
    Laursen LC; Iversen E
    Ugeskr Laeger; 1991 Jun; 153(26):1881-2. PubMed ID: 1862577
    [No Abstract]   [Full Text] [Related]  

  • 6. [Helicobacter pylori eradication in ulcer patients. Quality of life improves, costs decline].
    MMW Fortschr Med; 2003 Aug; 145(33-34):55. PubMed ID: 14526577
    [No Abstract]   [Full Text] [Related]  

  • 7. [Limits for how much are we prepared to pay for drugs].
    Harild M
    Ugeskr Laeger; 2003 Oct; 165(41):3940. PubMed ID: 14579560
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical and economical efficacy of the different variants of inpatient treatment of ulcerative diseases].
    Vakhrushev IaM; Muravtseva OV
    Eksp Klin Gastroenterol; 2008; (4):28-30. PubMed ID: 19145900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Utilization of antibiotics in Sweden during 1991--a less honourable record].
    Norrby R
    Lakartidningen; 1992 May; 89(20):1757-8, 1763. PubMed ID: 1598030
    [No Abstract]   [Full Text] [Related]  

  • 10. Topical sucralfate post-hemorrhoidectomy: an affordable and feasible treatment option.
    Chaudhary ND; Rivadeneira DE; Ranire-Maguire M; Corman ML
    Dis Colon Rectum; 2008 Dec; 51(12):1857; author reply 1858. PubMed ID: 18726650
    [No Abstract]   [Full Text] [Related]  

  • 11. Drugs still influence health costs, but trend abating.
    Capitation Rates Data; 2003 Oct; 8(10):114-20. PubMed ID: 14621548
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of the effectiveness of tri- and quadricomponent eradication therapy in patients with peptic ulcer].
    Butorov IV; Osoianu IuP; Butorov SI; Maksimov VV
    Klin Med (Mosk); 2005; 83(12):50-3. PubMed ID: 16502725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Society against heartburn].
    Lazebnik LB; Bordin DS; Masharova AA
    Eksp Klin Gastroenterol; 2007; (4):5-10. PubMed ID: 18411440
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical and economic analysis of the application of ranitidine and famotidine for treatment of duodenal ulcers].
    Guseĭnzade MG
    Eksp Klin Gastroenterol; 2005; (4):92-101. PubMed ID: 16255545
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of a Helicobacter pylori treatment strategy on health care expenditures in patients with peptic ulcer disease and dyspepsia.
    Kearney DJ; Liu CF; Crump C; Brousal A
    Am J Gastroenterol; 2003 Sep; 98(9):1952-62. PubMed ID: 14499771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of the reimbursement scheme on the consumption of drugs].
    Madsen UK
    Ugeskr Laeger; 2009 Mar; 171(10):783-6. PubMed ID: 19265600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy may be overused at the end of life.
    Gottlieb S
    BMJ; 2001 May; 322(7297):1267. PubMed ID: 11375223
    [No Abstract]   [Full Text] [Related]  

  • 18. Expenditures for prescription drugs: too much or not enough?
    Schumock GT; Walton SM
    Healthc Financ Manage; 2003 Oct; 57(10):34-8, 41. PubMed ID: 14560578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acid-related disorders and use of antisecretory medication.
    Lassen AT
    Dan Med Bull; 2007 Feb; 54(1):18-30. PubMed ID: 17349216
    [No Abstract]   [Full Text] [Related]  

  • 20. [Correct drug utilization--a national economy perspective].
    Jørgensen E
    Tidsskr Nor Laegeforen; 2006 Mar; 126(7):934. PubMed ID: 16554889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.